Alliance Medical Products completes high volume vial filling line at Irvine California facility

NewsGuard 100/100 Score

Alliance Medical Products, Inc. ("AMP") announced today, at the 9th Annual Contracting and Outsourcing Conference, its completion of a high volume vial filling line.

“Our participation in the Contracting and Outsourcing Conference in previous years has allowed us to build relationships with some of the leading pharmaceutical and biotechnology companies in the world”

"We are very excited to announce the completion of a high volume vial filling line located at our 54,000 square foot filling facility in Irvine California," said Juan Valdes, President and CEO. "The 8 head Conquest line has a capacity of 150,000 vials per shift and is supported by an inline vial washer, depyrogenation tunnel and 12 spindle capper. The line supports nitrogen purge or blanket and vial sizes ranging from 2mL to 150mL. The addition of this line further extends our ability to provide a complete range of developmental, clinical and commercial contract manufacturing services to large and small organizations."

Steve Tulk, Vice President of Business Development and Kevin O'Brien, Director of Sales, will be available to discuss the new high volume filling line during the conference.

"Our participation in the Contracting and Outsourcing Conference in previous years has allowed us to build relationships with some of the leading pharmaceutical and biotechnology companies in the world," said Valdes.

Source:

ALLIANCE MEDICAL PRODUCTS, INC

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
Common HIV drugs linked to reduced Alzheimer's disease risk